Is average adherence to HIV antiretroviral therapy enough? (Q42347783)

27 October 2017

0 references

Is average adherence to HIV antiretroviral therapy enough? (English)

1 reference

27 October 2017

anti-retroviral agent

0 references

1

David R Bangsberg

1 reference

27 October 2017

2

Steven G Deeks

1 reference

27 October 2017

1 October 2002

1 reference

Journal of General Internal Medicine

27 October 2017

1 reference

27 October 2017

17

1 reference

27 October 2017

10

1 reference

27 October 2017

812-813

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1525-1497.2002.20812.x

27 October 2017

0 references

cites work

A prospective study of predictors of adherence to combination antiretroviral medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

29 May 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

29 May 2018

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.20812.X

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Full adherence to HAART: is it really necessary?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

A comparison study of multiple measures of adherence to HIV protease inhibitors.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495121

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

17 August 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.20812.X

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.20812.X

The era of adherence to HIV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.20812.X

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.20812.X

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.2002.20812.X

Patient compliance and drug failure in protease inhibitor monotherapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12390559

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12390559

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1046/J.1525-1497.2002.20812.X

1 reference

PMCID

1495121

Dimensions Publication ID

27 October 2017

0 references

1 reference

27 October 2017

1 reference

PMCID

1495121